Ignite Creation Date:
2024-10-25 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06598527
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumav Plus Platinum-based Chemotherapy As Neoadjuvant Therapy in Patients with Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer a Phase Ⅲ Randomized Multicenter Prospective Study
Sponsor:
None
Organization:
None
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2024-09-14
First Submit QC Date:
None
Study First Post Date:
None
Study First Post Date Type:
None
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-14
Last Update Post Date:
None
Last Update Post Date Type:
None